Sigyn Therapeutics (SIGY) Total Debt Growth (1y) (2017 - 2025)
Powered by 
Analysis
Sigyn Therapeutics (SIGY) Total Debt Growth (1y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.00 Bn | 175.40 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 127.82 Bn | 122.60 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.94 Bn | 108.12 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 104.40 Bn | 100.92 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 63.93 Bn | 63.39 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.67 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 20.67 Bn | 20.19 Bn | 684.20 Mn | 12.29% |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | 197.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 197.27% |
| Jun 30, 2025 | 44.35% |
| Mar 31, 2025 | -3.01% |
| Dec 31, 2024 | 109.21% |
| Sep 30, 2024 | -39.25% |
| Jun 30, 2024 | -32.31% |
| Mar 31, 2024 | 0.23% |
| Dec 31, 2023 | 15.59% |
| Sep 30, 2023 | 94.51% |
| Jun 30, 2023 | 178.27% |
| Mar 31, 2023 | 250.55% |
| Dec 31, 2022 | 152.88% |
| Sep 30, 2022 | 121.32% |
| Jun 30, 2022 | 52.14% |
| Mar 31, 2022 | 21.90% |
| Dec 31, 2021 | 24.78% |
| Sep 30, 2021 | -77.35% |
| Jun 30, 2021 | -79.33% |
| Mar 31, 2021 | -80.70% |
| Dec 31, 2020 | -82.52% |